Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)

ClinicalTrials.gov ID: NCT05425732

Public ClinicalTrials.gov record NCT05425732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Active Comparator-controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3, randomized, double-blind, active comparator-controlled study of the safety, tolerability, and immunogenicity of V116 compared to PCV20 (pneumococcal 20-valent conjugate vaccine (\[Prevnar 20™ / APEXXNAR™\]) in pneumococcal vaccine-naïve adults. It is hypothesized that V116 is noninferior to PCV20 for the common serotypes and superior to PCV20 for the unique serotypes as assessed by serotype specific opsonophagocytic activity (OPA) 30 days postvaccination. It is also hypothesized that V116 in participants 18 to 49 years of age immunobridges to V116 in participants 50 to 64 years of age as assessed by serotype specific OPA geometric mean titers (GMTs) 30 days postvaccination for all 21 serotypes in V116. Participants ≥50 years of age will be enrolled in Cohort 1, and participants 18 to 49 years of age will be enrolled in Cohort 2.

Study identification

NCT ID
NCT05425732
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
2,663 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2022 (Actual)
Primary completion
May 18, 2023 (Actual)
Completion
May 18, 2023 (Actual)
Last update posted
Oct 26, 2024

2022 – 2023

United States locations

U.S. sites
60
U.S. states
21
U.S. cities
55
Facility City State ZIP Site status
Central Research Associates ( Site 0067) Birmingham Alabama 35205 —
Lenzmeier Family Medicine/CCT Research ( Site 0006) Glendale Arizona 85308 —
Desert Clinical Research/ CCT Research ( Site 0040) Mesa Arizona 85213 —
Foothills Research Center/ CCT Research ( Site 0021) Phoenix Arizona 85044 —
Fiel Family and Sports Medicine, PC/CCT Research ( Site 0003) Tempe Arizona 85283 —
Baptist Health Center For Clinical Research ( Site 0019) Little Rock Arkansas 72205 —
Southland Clinical Research Center-Research ( Site 0054) Fountain Valley California 92708 —
Sunwise Clinical Research ( Site 0024) Lafayette California 94549 —
Chemidox Clinical Trials ( Site 0048) Lancaster California 93534 —
Paradigm Clinical Research Centers, Inc ( Site 0018) Redding California 96001 —
Peninsula Research Associates ( Site 0079) Rolling Hills Estates California 90274 —
Acclaim Clinical Research ( Site 0083) San Diego California 92120 —
Millennium Clinical Trials ( Site 0013) Simi Valley California 93065 —
Lynn Institute of Denver ( Site 0012) Aurora Colorado 80012 —
Paradigm Clinical Research Centers, Inc ( Site 0027) Wheat Ridge Colorado 80033 —
JEM Research Institute ( Site 0072) Atlantis Florida 33462 —
Alliance for Multispecialty Research, LLC ( Site 0015) Coral Gables Florida 33134 —
Hillcrest Medical Research ( Site 0049) DeLand Florida 32720 —
East Coast Institute for Research, LLC ( Site 0070) Jacksonville Florida 32204 —
East Coast Institute for Research ( Site 0071) Lake City Florida 32055 —
L&C Professional Medical Research Institute ( Site 0025) Miami Florida 33144 —
Advanced Medical Research Institute ( Site 0014) Miami Florida 33174 —
Headlands Research Orlando ( Site 0031) Orlando Florida 32819 —
Genesis Clinical Research, LLC ( Site 0016) Tampa Florida 33603 —
Clinical Research Trials of Florida ( Site 0007) Tampa Florida 33607 —
Palm Beach Research Center ( Site 0060) West Palm Beach Florida 33409 —
Clinical Research Prime ( Site 0010) Idaho Falls Idaho 83404 —
Solaris Clinical Research ( Site 0008) Meridian Idaho 83646 —
Versailles Family Medicine / CCT Research ( Site 0063) Versailles Kentucky 40383 —
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0038) Troy Michigan 48098 —
Alliance for Multispecialty Research, LLC ( Site 0026) Kansas City Missouri 64114 —
Skyline Medical Center/CCT Research ( Site 0028) Elkhorn Nebraska 68022 —
Methodist Physicians Clinic/CCT Research ( Site 0058) Fremont Nebraska 68025 —
Meridian Clinical Research, LLC ( Site 0045) Norfolk Nebraska 68701 —
Healor Primary Care / CCT Research ( Site 0056) Las Vegas Nevada 89102 —
Excel Clinical Research, LLC ( Site 0077) Las Vegas Nevada 89109 —
Santa Rosa Medical Centers of Nevada / CCT Research ( Site 0029) Las Vegas Nevada 89119 —
Smith Allergy & Asthma Specialists-Corning Center for Clinical Research ( Site 0032) Horseheads New York 14845 —
Aventiv Research Inc ( Site 0044) Columbus Ohio 43213 —
Advanced Medical Research ( Site 0002) Maumee Ohio 43537 —
Lynn Institute of Norman ( Site 0001) Norman Oklahoma 73072 —
Lynn Health Science Institute ( Site 0005) Oklahoma City Oklahoma 73112 —
Lynn Institute of Tulsa ( Site 0084) Tulsa Oklahoma 74135 —
Summit Headlands ( Site 0047) Portland Oregon 97210 —
Velocity Clinical Research, Greenville ( Site 0043) Greenville South Carolina 29615 —
Trial Management Associates ( Site 0089) Myrtle Beach South Carolina 29572 —
Tekton Research, Inc. ( Site 0053) Austin Texas 78745 —
WR-Global Medical Research, LLC ( Site 0065) Dallas Texas 75224 —
Elixir Research Group - W Houston ( Site 0068) Houston Texas 77077 —
Epic Clinical Research ( Site 0082) Lewisville Texas 75067 —
DCOL Center for Clinical Research ( Site 0051) Longview Texas 75605 —
Research Your Health ( Site 0042) Plano Texas 75093 —
IMA Clinical Research San Antonio ( Site 0009) San Antonio Texas 78229 —
VIP Trials ( Site 0086) San Antonio Texas 78230 —
Dynamed Clinical Research, LP d/b/a DM Clinical Research-DM Clinical Research ( Site 0036) Tomball Texas 77375 —
Olympus Family Medicine/CCT Research ( Site 0074) Holladay Utah 84117 —
South Ogden Family Medicine/ CCT Research ( Site 0022) Ogden Utah 84405 —
Charlottesville Medical Research ( Site 0034) Charlottesville Virginia 22911 —
Health Research of Hampton Roads, Inc. ( Site 0004) Newport News Virginia 23606 —
MultiCare Rockwood Cheney Clinic ( Site 0037) Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05425732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2024 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05425732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →